-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
June 01, 2010 - A subsequent publication presents exploratory analyses in
which a subset of ICH patients was described … We have described our assessment of heterogeneity in the
section titled “Clinical considerations of … As
described above, the report also emphasizes that it focuses
only on in-hospital applications of … As described above, we favored the use of this case-
based unit of analysis because of its advantages … As described
above, for each indication, the report includes a section
discussing heterogeneity and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-youth-disposition-comments.pdf
April 10, 2025 - The inclusion and
exclusion criteria in
Section 2.4.2 that is also
listed in Table 1
described the … The
details listed in the
AHRQ Methods Guide
are described in the
subsequent sections
(Sections … We
described the approach
in Section 2.4.6,
Grading the Strength of
Evidence in the full
report … Peer Reviewer #2 Methods General Methods Comments: The methods are well-
written and described. … The psychological
outcomes are described
in the text per study.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hro-rapid-research.pdf
May 01, 2025 - The VA’s
eligibility criteria for the evidence brief was broader, including articles that described … Of those, 23 articles were included: 8 described implementation
frameworks, 9 described metrics, and … Using the ROBINS-I tool, the VHA HRH implementation study described above
was judged to be at serious … The resources required for HRO principles implementation have been described in
the literature but have … We only included studies that
explicitly described implementation of an HRO model in totality—i.e.,
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-topic-refinement.pdf
November 01, 2022 - A recent review described 27 CED determinations from 2005 to
2022 in 8 therapeutic areas.8 The duration … Two of these experts were part of the Key Informant Panel
described below. … As described above, we focused on extracting
recommendations for generating rigorous real-world evidence … As
item E states that outcomes
are described in the protocol,
it is expected that this will be
described … If protocols that are developed by sponsors of the
product, or by other investigators, are described
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-227-noninvasive-nonpharm-chronic-pain-comments.pdf
April 16, 2020 - We defined
them a priori as described in the report. … Exercises was
categorized as described in Appendix F. … Moreover you state explicitly
that "Our review is intended to address some of the needs
described in … The
discussion acknowledges the heterogeneity of what
was described as usual care across studies. … Evaluation of combination treatments was beyond
the scope of this report as described in the protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/reporting.ppt
September 01, 2009 - Methods: Eligibility Criteria (II)
This slide offers examples of how studies and participants were described … Methods: Eligibility Criteria (III)
This slide offers examples of how interventions and outcomes were described … It appeared that 22 studies did not meet the inclusion criteria as described. … Although the last two described a period of 24 months during which they were conducted, only the first
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-appendix-3.xlsx
June 24, 2022 - risk of further distribution and use without the appropriate permissions/agreements; data retention is described … levels of data quality by data element (and the potential implications on study findings) should be described … levels of data quality by data element (and the potential implications on study findings) should be described
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol-amendment.pdf
March 22, 2023 - Criteria for Inclusion/Exclusion of Studies in the Review:
We will use the inclusion/exclusion criteria described … Effectiveness Reviews.18 Studies will be rated
as being “low,” “moderate,” or “high” risk of bias as described … initially assessed by one researcher
for each clinical outcome (see PICOTS) by using the approach described … The strength of the evidence may be downgraded based on the limitations described above. … existence of plausible unmeasured confounders), if there are
no downgrades on the primary domains, as described
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/telehealth-women-protocol.pdf
June 21, 2021 - PICOTS
The populations, interventions, comparators, outcomes, and settings (PICOTS) of interest are
described … Review
The criteria for inclusion and exclusion of individual studies are based on the KQs and
PICOTS described … Individual Studies: Applicability of individual studies will be considered
according to the approach described … For KQ1a, c, d (effectiveness) we will use the
approach described in the Methods Guide for Effectiveness … Assessing Applicability of Evidence Base: Applicability will be considered according to the
approach described
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-275-people-with-disabilities-disposition-comments.pdf
September 16, 2024 - the Technical Expert Panel, the
AHRQ Task Order Officer, and content experts on the EPC
team, as described … As described in the Methods section (“Systematic Review
Procedures”), we considered various study design … We described factors
as being barriers or facilitators as reported in the included
studies. … TEP Reviewer
#1
Results Overall, the Results section was clearly described. … The scope of the systematic review did include both
children/ adolescents and adults, as described in
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatigue-sleepiness-protocol.pdf
July 01, 2023 - We will search for recent high quality systematic reviews defined using the criteria for
“Good” described … Study design not specified, or
no control described;
Qualitative studies with no
quantitative component … We will search for recent high quality systematic reviews defined using the criteria for “Good” described
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-executive-summary-2023-update.pdf
January 01, 2023 - Program Methods Guide
(https://effectivehealthcare.ahrq.gov/topics/cer-methods-guide/overview), as described … effectivehealthcare.ahrq.gov/topics/cer-methods-guide/overview
3
Results
The included RCTs are described … in Table B and the included observational studies
are described in Table C.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-224-depression-children-comments.pdf
April 10, 2020 - Peer reviewer #1
Results Characteristics of the studies are for the most part clearly described. … Limitations of the review/studies are
described adequately, although more attention to the definition … The inclusion and exclusion criteria were described using table 4
Thank you. … The
target audience for the report is not well described. … The search included collaborative care
settings, so this is described but,
unfortunately, no studies
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-231-dementia-care-interventions-disposition-comments.pdf
July 31, 2020 - It is
described as ‘traditional’ is there a theoretical basis? … Peer Reviewer #4 Methods Inclusion and exclusion criteria well described. … In tables, analytic studies are
described as medium risk of bias etc but in methods and
figure the … Characteristics of the studies are clearly described. … Strengths and weaknesses/limitations of the review are
described adequately (p. 117-118).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-improving-health-systems-access.pdf
August 01, 2019 - The three recommendations – along with
the summary themes from each EPC project – are described in the … findings, Figure 2
depicts the EPC pilot projects on the dissemination to implementation continuum, as described … Data
visualization has been previously described as “encompass[ing] a broad set of techniques for
representing … These companion products can be described as
dissemination products, interactive data visualization
-
effectivehealthcare.ahrq.gov/sites/default/files/diverticulitis-comments.pdf
October 12, 2020 - Rates of
complications are described. … Also the
methods to assess the risk of bias were
described along with details of data
synthesis and … We have more fully described the
absolute rates, including NNT in the text
of the Results.
-
effectivehealthcare.ahrq.gov/sites/default/files/covariate-selection-chapter-7.pptx
January 01, 2013 - This type of design is described as a “per protocol” analysis. … arises when the variable set is insufficient to remove all confounding; for this reason, Z-bias has been described … relies primarily on statistical associations to select variables for control of confounding and can be described … The problem, as described above, is that colliders, intermediate variables, and instruments can all statistically … important covariates, discussed the potential for unmeasured confounding and misclassification, and described
-
effectivehealthcare.ahrq.gov/sites/default/files/estimation-and-reporting_chapter-3.pptx
January 01, 2013 - Slide 1
Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-protein-intake-disposition-comments.pdf
November 22, 2024 - We refined how these outcomes were described and categorized.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/practical-considerations.pdf
March 01, 2022 - meta-analysis, performing narrative synthesis,
assessing strength of evidence, and generating conclusions are described … challenges, detailed in
a recent survey of participants in a LSR pilot project.10 This publication described … Challenges along with
lessons learned are also described in this document. … or as new
formulations/dosing
strategies are introduced;
ensure that scope
changes are clearly
described